跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
醫學系婦產學科
醫學院
醫學系
概覽
指紋
網路
人員
(2)
研究成果
(202)
指紋
查看啟用 醫學系婦產學科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Endometriosis
86%
Uterine Cancer
85%
Krukenberg Tumor
79%
Recurrent Disease
79%
Arrhythmogenesis
74%
Retrospective Cohort Study
72%
Systematic Review
70%
Uterine Myomectomy
67%
Myoma
66%
Adenomyosis
63%
Neoplasm
62%
Overall Survival
61%
Ovarian Cancer
60%
Fibroblast
49%
Obstetrics
48%
Gynecology
48%
Cervical Cancer
44%
Diseases
44%
Gestational Age
43%
Pelvis
41%
Cystectomy
41%
Laparoscopic Surgery
41%
Atrial Fibrillation
40%
Pregnancy
40%
Cisplatin
39%
Uterus Sarcoma
39%
Induced Pluripotent Stem Cell
39%
Calcium Homeostasis
39%
Calcium Ion
38%
Operation Duration
35%
Isotopes of Calcium
34%
Clear Cell Carcinoma
34%
Cyclooxygenase 2
33%
Cytoreductive Surgery
33%
Cancer
33%
Uterine Fibroid
32%
Angiogenesis
31%
Bleeding
30%
Progression Free Survival
30%
Uterine Tube Carcinoma
29%
Morcellation
29%
Stress Incontinence
29%
Endometrium Carcinoma
29%
Ventricular Outflow Tract
29%
Pulmonary Vein
29%
Adenocarcinoma
29%
Prognostic Factor
29%
Menorrhagia
29%
Doppler Flowmetry
27%
Doppler Ultrasound
27%
Recurrence Risk
27%
Dentigerous Cyst
26%
First Trimester Pregnancy
26%
Adverse Event
25%
Randomized Controlled Trial
24%
Surgery
23%
Gonadorelin Agonist
23%
Disease Free Survival
22%
Metastatic Carcinoma
22%
Endometrium
22%
Squamous Cell Carcinoma
22%
Breast Cancer
21%
Oxidative Stress
21%
Mesenchymal-Epithelial Transition
21%
Carcinoma
21%
Immunohistochemistry
21%
Vasculotropin
21%
Ovarian Tumor
21%
Blood Flow
21%
Chronic Kidney Disease
20%
Echography
20%
Western Blot
20%
Carcinosarcoma
19%
Gynecological Oncology
19%
Epithelial Cell
19%
Oncogene C Myc
19%
Liver Injury
19%
Laparotomy
19%
Polycystic Ovary Syndrome
19%
Protein P53
19%
Oxaliplatin
19%
Recurrent Ovarian Cancer
19%
Gut
19%
Heart Atrium Remodeling
19%
Cervix
19%
Hepatocyte
19%
Postmenopause
18%
Paclitaxel
17%
Retrospective Study
17%
Ifosfamide
17%
Carcinogenesis
16%
Dienogest
16%
Odds Ratio
16%
Cardiac Muscle Cell
16%
Pulsatility Index
16%
Cohort Analysis
16%
Proportional Hazards Model
16%
Hazard Ratio
16%
Left Atrium
16%
Congestive Heart Failure
15%
Keyphrases
Taiwan
100%
Endometriosis
83%
Induced Pluripotent Stem Cells (iPSCs)
79%
Confidence Interval
64%
Taiwanese
64%
Retrospective Cohort Study
63%
Endometrial Cancer
62%
Adenomyosis
61%
Epithelial Ovarian Cancer
61%
Estrogen
55%
Overall Survival
54%
Calcium Homeostasis
50%
Pulmonary Vein
46%
Arrhythmogenesis
45%
Myomectomy
41%
Fibrogenesis
40%
Postmenopausal Women
40%
Ovarian Cancer
40%
Uterine Sarcoma
39%
Laparoscopic Surgery
39%
Cervical Cancer
37%
Gonadotropin-releasing Hormone
36%
Laparoscopic Myomectomy
35%
Ovarian Cancer Patients
35%
Recurrence Rate
33%
Gestational Age
32%
Cancer Patients
31%
Cisplatin
31%
Angiogenesis
31%
Operative Time
30%
Fallopian Tube Carcinoma
29%
Bipolar Coagulation
29%
Uterine Vessels
29%
Taiwanese Women
29%
Single Port
29%
Rare Case Report
29%
Endometrial Carcinoma
29%
Laparoscopic Cystectomy
29%
Overexpression
29%
Cyclooxygenase-2
28%
Obstetrics
27%
Advanced Stage
26%
Electrical Activity
26%
Randomized Controlled Trial
26%
Odds Ratio
26%
Prognostic Factors
26%
Ovarian Clear Cell Carcinoma
24%
Adverse Events
24%
Power Doppler Ultrasound
24%
Mouse Model
23%
Normal Pregnancy
23%
Agonist Treatment
23%
Hazard Ratio
23%
Heart Failure
23%
Transplantation
23%
Levonorgestrel-releasing Intrauterine System (LNG-IUS)
23%
Atrial Arrhythmogenesis
22%
Laparoscopy
22%
Fallopian Tube
22%
Progression-free Survival
22%
Single-port Laparoscopic
22%
Older Women
21%
Survival Outcomes
21%
Conventional Laparoscopic
21%
Stress Urinary Incontinence
21%
Human Atrial Fibroblasts
21%
Myoma
21%
Cyclooxygenase-2 Expression
21%
C-Myc
20%
Hepatoprotective
20%
Uterus
20%
Liver Injury
19%
Symptomatic Uterine Fibroids
19%
Gynecologic Oncology Group
19%
Cervical Squamous Cell Carcinoma
19%
Invasive Cervical Cancer
19%
Ultraminilaparotomy
19%
ST6GAL1
19%
Parasitic Myoma
19%
Laparoscopic Morcellation
19%
PRISMA
19%
Ovarian Dermoid Cyst
19%
Endometrial Epithelial Cells
19%
Young Women
19%
Endometrioma Recurrence
19%
Cisplatin-based Chemotherapy
19%
Laparotomy
19%
Sialyltransferase
19%
Upper Abdominal Pain
19%
Gynecological Laparoscopic Surgery
19%
Estrogen Receptor
19%
Transobturator
19%
Laparoscopic Ovarian Drilling
19%
Wound Healing
19%
Mini
19%
Polycystic Ovary Syndrome
19%
Round Spermatid Injection
19%
Staging System
19%
Endometrial Cancer Staging
19%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
19%